NCQA President Talks About the Promise and Challenge of EHRs


By Cindy Atoji 

May 6, 2008 | The “Patients Centered Medical Homes” initiative is the latest tool touted by the National Committee for Quality Assurance to help drive adoption of electronic medical records says Margaret O’Kane, president of the not-for-profit NCQA.

A Patient Centered Medical Home is a model of health care delivery that revolves around a primary care physician who coordinates all other care needed for a patient. Care is facilitated by registries, and health IT, to make sure patients get the care when and where they need it, from hospitals, nursing homes, home health agencies, etc. This concept, along with P4P (Pay for Performance), is trying to move physicians where they need to go, says O’Kane.

“It’s about trying to encourage the creation of registries and customized information about each patient. What IT actually makes possible now is care management at the delivery system level,” she says. NCQA is best known for its report cards that look at the nation’s health plans. Digital HealthCare & Productivity spoke with O’Kane about NCQA’s programs and the role of health IT in these accrediting and certification programs.

DHP: Your organization has a long record of measuring health care quality. How have changes in technology affected quality over the last three to five years?

O’Kane: The organizations that have adopted EHRs and made them work are really showing us what can be done. It’s become increasingly urgent to adopt technology, but it’s clear that it’s very complex to adopt an EHR. I know that Kaiser bought the Epic system and they had to re-tool a lot to make it do what they wanted it to do. Many products out there are not searchable; the data is not encoded, or you have a paper medical record concept up on a screen.

I think the difficulty of implementation and cost of EHRs is a big barrier. People are afraid they’re going to buy the wrong one or that it’s not going to work well for them. Frankly, I don’t understand why there aren’t the kinds of solutions we see in other areas where the computer is part of a package of services that basically solve your problem. Because so much re-engineering of the practice process is required, the idea that each little practice will have the time and experience to accomplish this efficiently strikes me as unrealistic.

DHP: What do you suggest?

O’Kane: To your vendor readership, I’m very impressed when I hear of companies who send representatives around to actually sit with the people who are using the product. The more time the vendors spend in practices, and really understand what the needs are, the better. There are often failures—anecdotes about people getting computers and not using them. These stories lead people who want to buy [EHRs] to become afraid they’re going to buy the Betamax version.

The industry needs to meet customers where they are and also look at what’s possible, not just trying to re-engineer around the current delivery cycle. I think that’s where the medical home makes a real contribution. It makes it very clear what’s needed and then you can re-engineer the process around that. This provides the bones of what I think the 21st century practice should look like and what the process re-engineering needs are.

DHP: What further steps are needed to make performance measurements more effective?

O’Kane: We’ve come a long way and have many performance measurements to point to these days, done by us and others in the space: the Joint Commission, the Physician Consortium for Practice Improvement, the National Quality Forum, etc. So there’s no shortage of measures. But where measurements meet a fragmented delivery system is where you have a problem, because it’s not clear who’s accountable, and that leads to narrowing the frame of accountability. So there’s no substitute for organization in the delivery system.

DHP: NCQA recently released the State of Health Care Quality, 2007. What are some of the highlights of the report?

O’Kane: This was our eleventh survey, and we found a promising upward trend in the number of accountable health plans and an increase in the number of Americans enrolled in plans that measure and report on their health care quality. There was also an increase in HEDIS (Health Plan Employer Data and Information Set, a set of health plan performance measures) reporting by PPO plans. These plans, which just two years ago reported little or no quality data, are now embracing the quality agenda. Last year, 141 plans submitted HEDIS data on 21 million of their members. This is up sharply from the 80 PPOs that reported HEDIS in 2005, a lot of progress in a short period.

So that’s kind of a watershed for us, to be moving beyond HMOs and to have a large number of PPO lives that have begun to report. The story continues to be that we see great progress in performance in a number of areas.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .